English, , 81kb
Written Statement to Ministers’ Round Table. David Morgan, Administrator, Health Division, OECD. Medical Tourism and Global Health Congress, Los Angeles, October 26th-28th, 2009.
English, Excel, 376kb
The United States spent 16% of its national income (GDP) on health in 2007, which is by far, the highest share in the OECD. This presentation was given by Mark Pearson, Head of OECD Health Division, to the U.S Senate Special Committee on Aging.
Slovak, Excel, 1,115kb
Slovak translation of Health Working Paper No. 28: "Pharmaceutical Pricing and Reimbursement Policies in Sweden", by Pierre Moïse and Elizabeth Docteur.
The workshop discussed existing sector, national, or international approaches for assessment of sustainability of bio-based products, such as bio-based chemicals, bio-based plastics, enzymes, bio-based materials, and biofuels.
Synthetic biology is a transformative set of technologies which offer great opportunities for the construction of bioengineered parts, devices and microorganisms.
The number of doctors per capita increased 2% per year on average across OECD countries between 1990 and 2007, but in some countries the trend is reversing.
An OECD workshop hosted by Canada will be held on July 23-24, 2009 in Montréal, Québec immediately after the 6th World Congress on Industrial Biotechnology and Bio-processing to discuss progress over the past 5 years in the methodologies used for sustainability assessment of bio-based products.
OECD Health Working Paper No. 46 presents the findings of health survey data from Australia, Canada, England and Korea. It shows that education appears to be associated with a lower likelihood of obesity, especially among women.
This OECD project is concerned with identifying main blockages and policies, incentives, or institutional arrangements under which ICTs can deliver the desired efficiency and quality improvements.
English, , 2,570kb
The 2009 edition brings together the latest available economic and activity data on biotechnology and innovation for 22 OECD members and four non-member countries. It builds on the extensive work of the OECD and national experts to improve the comparability of biotechnology statistics.